JPMorgan Chase & Co’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$74.4K Sell
101,780
-121,345
-54% -$88.7K ﹤0.01% 4922
2025
Q1
$180K Buy
223,125
+173,384
+349% +$140K ﹤0.01% 4478
2024
Q4
$68.6K Sell
49,741
-11,642
-19% -$16.1K ﹤0.01% 4903
2024
Q3
$63.8K Buy
61,383
+1,073
+2% +$1.12K ﹤0.01% 4905
2024
Q2
$104K Sell
60,310
-166,769
-73% -$289K ﹤0.01% 4579
2024
Q1
$543K Sell
227,079
-208,587
-48% -$499K ﹤0.01% 3910
2023
Q4
$1.45M Sell
435,666
-4,944,542
-92% -$16.5M ﹤0.01% 3323
2023
Q3
$20.1M Sell
5,380,208
-348,710
-6% -$1.3M ﹤0.01% 1505
2023
Q2
$24.5M Sell
5,728,918
-253,617
-4% -$1.08M ﹤0.01% 1418
2023
Q1
$40.9M Sell
5,982,535
-522,328
-8% -$3.57M 0.01% 1084
2022
Q4
$51.5M Buy
6,504,863
+379,618
+6% +$3.01M 0.01% 978
2022
Q3
$58.9M Sell
6,125,245
-360,986
-6% -$3.47M 0.01% 890
2022
Q2
$47M Sell
6,486,231
-89,312
-1% -$647K 0.01% 991
2022
Q1
$84.9M Sell
6,575,543
-114,205
-2% -$1.47M 0.01% 846
2021
Q4
$107M Sell
6,689,748
-481,119
-7% -$7.68M 0.01% 782
2021
Q3
$115M Buy
7,170,867
+1,076,809
+18% +$17.3M 0.01% 752
2021
Q2
$84.3M Buy
6,094,058
+897,952
+17% +$12.4M 0.01% 905
2021
Q1
$75.9M Buy
5,196,106
+242,524
+5% +$3.54M 0.01% 909
2020
Q4
$86.1M Buy
4,953,582
+223,225
+5% +$3.88M 0.01% 768
2020
Q3
$89M Buy
4,730,357
+192,453
+4% +$3.62M 0.02% 683
2020
Q2
$81M Buy
4,537,904
+413,659
+10% +$7.39M 0.02% 684
2020
Q1
$66.9M Buy
4,124,245
+666,775
+19% +$10.8M 0.02% 666
2019
Q4
$62.3M Sell
3,457,470
-215,176
-6% -$3.87M 0.01% 773
2019
Q3
$74.4M Sell
3,672,646
-591,159
-14% -$12M 0.01% 717
2019
Q2
$91.6M Sell
4,263,805
-478,784
-10% -$10.3M 0.02% 657
2019
Q1
$64.7M Buy
4,742,589
+1,010,708
+27% +$13.8M 0.01% 763
2018
Q4
$33.8M Buy
3,731,881
+1,543,553
+71% +$14M 0.01% 967
2018
Q3
$36.1M Sell
2,188,328
-44,570
-2% -$735K 0.01% 1083
2018
Q2
$31.3M Buy
2,232,898
+187,830
+9% +$2.63M 0.01% 1131
2018
Q1
$22.6M Buy
2,045,068
+120,574
+6% +$1.33M ﹤0.01% 1294
2017
Q4
$16.9M Buy
1,924,494
+173,292
+10% +$1.52M ﹤0.01% 1490
2017
Q3
$23.6M Buy
1,751,202
+359,491
+26% +$4.85M 0.01% 1247
2017
Q2
$20M Sell
1,391,711
-238,776
-15% -$3.43M ﹤0.01% 1301
2017
Q1
$34.5M Buy
1,630,487
+65,619
+4% +$1.39M 0.01% 1020
2016
Q4
$44.1M Sell
1,564,868
-366,111
-19% -$10.3M 0.01% 869
2016
Q3
$51.7M Buy
1,930,979
+54,042
+3% +$1.45M 0.01% 746
2016
Q2
$31.7M Sell
1,876,937
-245,614
-12% -$4.15M 0.01% 963
2016
Q1
$45.1M Buy
2,122,551
+466,388
+28% +$9.9M 0.01% 784
2015
Q4
$38M Buy
1,656,163
+281,193
+20% +$6.46M 0.01% 853
2015
Q3
$27.6M Sell
1,374,970
-149,941
-10% -$3M 0.01% 981
2015
Q2
$44.1M Buy
1,524,911
+240,208
+19% +$6.94M 0.01% 875
2015
Q1
$39.3M Buy
1,284,703
+549,384
+75% +$16.8M 0.01% 934
2014
Q4
$12M Buy
+735,319
New +$12M ﹤0.01% 1581